112 related articles for article (PubMed ID: 7002354)
1. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
[TBL] [Abstract][Full Text] [Related]
2. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
[TBL] [Abstract][Full Text] [Related]
3. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
[TBL] [Abstract][Full Text] [Related]
4. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Klimt CR; Knatterud GL; Stamler J; Meier P
J Am Coll Cardiol; 1986 Feb; 7(2):251-69. PubMed ID: 2868029
[TBL] [Abstract][Full Text] [Related]
5. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
Circulation; 1980 Sep; 62(3):449-61. PubMed ID: 7398002
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
[TBL] [Abstract][Full Text] [Related]
8. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
9. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
[TBL] [Abstract][Full Text] [Related]
10. Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
J Chronic Dis; 1976 Oct; 29(10):625-42. PubMed ID: 789390
[TBL] [Abstract][Full Text] [Related]
11. Aspirin in coronary heart disease. Comparison of six clinical trials.
Canner PL
Isr J Med Sci; 1983 May; 19(5):413-23. PubMed ID: 6345461
[TBL] [Abstract][Full Text] [Related]
12. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
Vetrano A; Milani M; Corsini G
G Ital Cardiol; 1999 May; 29(5):524-8. PubMed ID: 10367219
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
[TBL] [Abstract][Full Text] [Related]
14. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
16. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
[TBL] [Abstract][Full Text] [Related]
17. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and secondary mortality after myocardial infarction.
Elwood PC; Sweetnam PM
Circulation; 1980 Dec; 62(6 Pt 2):V53-8. PubMed ID: 7438381
[TBL] [Abstract][Full Text] [Related]
20. Treatment of claudication with dipyridamole and aspirin.
Libretti A; Catalano M
Int J Clin Pharmacol Res; 1986; 6(1):59-60. PubMed ID: 3514494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]